A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä
Polyoxygenated Cyclohexenes and Other Constituents of Cleistochlamys kirkii Leaves (2017)


Nyandoro, S. S., Munissi, J. J. E., Gruhonjic, A., Duffy, S., Pan, F., Puttreddy, R., Holleran, J. P., Fitzpatrick, P. A., Pelletier, J., Avery, V. M., Rissanen, K., & Erdélyi, M. (2017). Polyoxygenated Cyclohexenes and Other Constituents of Cleistochlamys kirkii Leaves. Journal of Natural Products, 80(1), 114-125. https://doi.org/10.1021/acs.jnatprod.6b00759


JYU-tekijät tai -toimittajat


Julkaisun tiedot

Julkaisun kaikki tekijät tai toimittajatNyandoro, Stephen S.; Munissi, Joan J. E.; Gruhonjic, Amra; Duffy, Sandra; Pan, Fangfang; Puttreddy, Rakesh; Holleran, John P.; Fitzpatrick, Paul A.; Pelletier, Jerry; Avery, Vicky M.; et al.

Lehti tai sarjaJournal of Natural Products

ISSN0163-3864

eISSN1520-6025

Julkaisuvuosi2017

Volyymi80

Lehden numero1

Artikkelin sivunumerot114-125

KustantajaAmerican Chemical Society and American Society of Pharmacognosy

JulkaisumaaYhdysvallat (USA)

Julkaisun kielienglanti

DOIhttps://doi.org/10.1021/acs.jnatprod.6b00759

Julkaisun avoin saatavuusEi avoin

Julkaisukanavan avoin saatavuus


Tiivistelmä

Thirteen new metabolites, including the polyoxygenated cyclohexene derivatives cleistodiendiol (1), cleistodienol B (3), cleistenechlorohydrins A (4) and B (5), cleistenediols A–F (6–11), cleistenonal (12), and the butenolide cleistanolate (13), 2,5-dihydroxybenzyl benzoate (cleistophenolide, 14), and eight known compounds (2, 15–21) were isolated from a MeOH extract of the leaves of Cleistochlamys kirkii. The purified metabolites were identified by NMR spectroscopic and mass spectrometric analyses, whereas the absolute configurations of compounds 1, 17, and 19 were established by single-crystal X-ray diffraction. The configuration of the exocyclic double bond of compound 2 was revised based on comparison of its NMR spectroscopic features and optical rotation to those of 1, for which the configuration was determined by X-ray diffraction. Observation of the co-occurrence of cyclohexenoids and heptenolides in C. kirkii is of biogenetic and chemotaxonomic significance. Some of the isolated compounds showed activity against Plasmodium falciparum (3D7, Dd2), with IC50 values of 0.2–40 μM, and against HEK293 mammalian cells (IC50 2.7–3.6 μM). While the crude extract was inactive at 100 μg/mL against the MDA-MB-231 triple-negative breast cancer cell line, some of its isolated constituents demonstrated cytotoxic activity with IC50 values ranging from 0.03–8.2 μM. Compound 1 showed the most potent antiplasmodial (IC50 0.2 μM) and cytotoxic (IC50 0.03 μM, MDA-MB-231 cell line) activities. None of the compounds investigated exhibited translational inhibitory activity in vitro at 20 μM.


Vapaat asiasanatmetabolites; spectrometric analyses


Liittyvät organisaatiot

JYU-yksiköt:


Hankkeet, joissa julkaisu on tehty


OKM-raportointiKyllä

Raportointivuosi2017

JUFO-taso1


Viimeisin päivitys 2023-13-12 klo 16:54